U.S. Markets closed
  • S&P 500

    3,666.72
    -2.29 (-0.06%)
     
  • Dow 30

    29,969.52
    +85.73 (+0.29%)
     
  • Nasdaq

    12,377.18
    +27.82 (+0.23%)
     
  • Russell 2000

    1,848.70
    +10.67 (+0.58%)
     
  • Crude Oil

    45.73
    +0.09 (+0.20%)
     
  • Gold

    1,840.70
    +3.90 (+0.21%)
     
  • Silver

    24.08
    -0.01 (-0.05%)
     
  • EUR/USD

    1.2148
    +0.0032 (+0.2673%)
     
  • 10-Yr Bond

    0.9200
    -0.0280 (-2.95%)
     
  • Vix

    21.28
    +0.11 (+0.52%)
     
  • GBP/USD

    1.3453
    +0.0078 (+0.5798%)
     
  • USD/JPY

    103.8190
    -0.6050 (-0.5794%)
     
  • BTC-USD

    19,430.96
    +19,430.96 (+0.00%)
     
  • CMC Crypto 200

    382.19
    +7.79 (+2.08%)
     
  • FTSE 100

    6,490.27
    +26.88 (+0.42%)
     
  • Nikkei 225

    26,809.37
    +8.39 (+0.03%)
     

Homology Medicines: 1Q Earnings Snapshot

BEDFORD, Mass. (AP) _ Homology Medicines Inc. (FIXX) on Monday reported a loss of $23.9 million in its first quarter.

On a per-share basis, the Bedford, Massachusetts-based company said it had a loss of 64 cents.

The gene editing company posted revenue of $270,000 in the period.

Homology Medicines shares have decreased slightly since the beginning of the year. In the final minutes of trading on Monday, shares hit $22.25, a rise of 10% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on FIXX at https://www.zacks.com/ap/FIXX